Research Solutions (RSSS)
Publisher-independent software and transaction services for accessing, organizing and analyzing scientific literature.
$2.18
At close+0.02 (+0.93%)
In millions of USD, except per-share figures
| In millions | Q4 FY23Jun 2023 | Q1 FY24Sep 2023 | Q2 FY24Dec 2023 | Q3 FY24Mar 2024 | Q4 FY24Jun 2024 | Q1 FY25Sep 2024 | Q2 FY25Dec 2024 | Q3 FY25Mar 2025 | Q4 FY25Jun 2025 | Q1 FY26Sep 2025 | Q2 FY26Dec 2025 | Q3 FY26Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 10 | 10 | 12 | 12 | 12 | 12 | 13 | 12 | 12 | 12 | 12 |
| Cost of revenue | 6 | 6 | 6 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Gross profit | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 5 | |
| Research & development | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 |
| 3 | 4 | 3 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | |
| Selling & marketing | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 2 |
| General & administrative | 2 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 0 | −1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| 0 | 0 | 0 | 0 | −3 | 0 | −2 | 0 | 1 | 0 | 0 | 0 | |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | −1 | 0 | 0 | 0 |
| Income before tax | 0 | −1 | 0 | 0 | −3 | 1 | −2 | 0 | 2 | 1 | 1 | 1 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | 0 | −1 | 0 | 0 | −3 | 1 | −2 | 0 | 2 | 1 | 1 | 1 |
| Net income | 0 | −1 | 0 | 0 | −3 | 1 | −2 | 0 | 2 | 1 | 1 | 1 |
| EPS, basic | $0.01 | −$0.04 | −$0.00 | $0.00 | −$0.09 | $0.02 | −$0.07 | $0.01 | $0.07 | $0.02 | $0.02 | $0.03 |
| EPS, diluted | $0.01 | −$0.04 | −$0.00 | $0.00 | −$0.09 | $0.02 | −$0.07 | $0.01 | $0.07 | $0.02 | $0.02 | $0.03 |
| Weighted average shares, basic | 27 | 27 | 28 | 30 | 32 | 30 | 30 | 31 | 32 | 31 | 31 | 32 |
| Weighted average shares, diluted | 30 | 27 | 28 | 34 | 32 | 33 | 30 | 31 | 32 | 31 | 31 | 32 |
| EBITDA | 0 | −1 | 0 | 0 | −2 | 1 | 0 | 1 | 3 | 1 | 1 | 1 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 0 | −1 | 0 | 0 | −3 | 1 | 0 | 1 | 2 | 1 | 1 | 1 |